3.13
price up icon4.33%   0.13
after-market Dopo l'orario di chiusura: 3.10 -0.03 -0.96%
loading

Indaptus Therapeutics Inc Borsa (INDP) Ultime notizie

pulisher
11:21 AM

Will Indaptus Therapeutics Inc. stock recover faster than marketFit and Size Notes & lightweight options for faster days - ulpravda.ru

11:21 AM
pulisher
Jan 08, 2026

Indaptus Therapeutics appoints David Natan to board and audit committee - Investing.com

Jan 08, 2026
pulisher
Jan 08, 2026

Indaptus Therapeutics Appoints David Natan to Board - TipRanks

Jan 08, 2026
pulisher
Jan 08, 2026

Will Indaptus Therapeutics Inc. stock reach Wall Street targetsJuly 2025 Technicals & Entry Point Confirmation Alerts - ulpravda.ru

Jan 08, 2026
pulisher
Jan 08, 2026

How analysts rate Indaptus Therapeutics Inc. stock todayEarnings Risk Report & Weekly Hot Stock Watchlists - ulpravda.ru

Jan 08, 2026
pulisher
Jan 06, 2026

Why did INDP stock gain 12% today? - MSN

Jan 06, 2026
pulisher
Jan 02, 2026

Three Indaptus Therapeutics board members signal planned resignations - Investing.com

Jan 02, 2026
pulisher
Jan 02, 2026

Three Indaptus Therapeutics board members signal planned resignations By Investing.com - Investing.com India

Jan 02, 2026
pulisher
Jan 02, 2026

Indaptus Therapeutics announces upcoming board leadership transition - TipRanks

Jan 02, 2026
pulisher
Jan 02, 2026

Indaptus Therapeutics Announces Board Resignations - TradingView — Track All Markets

Jan 02, 2026
pulisher
Jan 02, 2026

Indaptus Therapeutics, Inc. (NASDAQ:INDP) Short Interest Up 25.9% in December - Defense World

Jan 02, 2026
pulisher
Dec 31, 2025

Indaptus Therapeutics looks to raise $2.25M in private placement - MSN

Dec 31, 2025
pulisher
Dec 30, 2025

Biotech Stocks To Keep An Eye OnDecember 24th - MarketBeat

Dec 30, 2025
pulisher
Dec 30, 2025

Indaptus Therapeutics Enters Into $6 Million Securities Purchase Agreement with Investor David E. Lazar - marketscreener.com

Dec 30, 2025
pulisher
Dec 30, 2025

Indaptus Enters Into $6 Million Securities Purchase Agreement with Investor David E. Lazar - The Globe and Mail

Dec 30, 2025
pulisher
Dec 30, 2025

Indaptus Therapeutics secures $6 million investment, names new chairman By Investing.com - Investing.com Nigeria

Dec 30, 2025
pulisher
Dec 29, 2025

Why Did INDP Stock Gain 12% Today? - Stocktwits

Dec 29, 2025
pulisher
Dec 29, 2025

Indaptus Therapeutics stock falls after $6 million securities deal By Investing.com - Investing.com Nigeria

Dec 29, 2025
pulisher
Dec 29, 2025

Indaptus Therapeutics stock falls after $6 million securities deal - Investing.com

Dec 29, 2025
pulisher
Dec 27, 2025

Penny Stocks Worth Watching – December 25th - Defense World

Dec 27, 2025
pulisher
Dec 25, 2025

What Does the Market Think About Indaptus Therapeutics Inc? - Benzinga

Dec 25, 2025
pulisher
Dec 24, 2025

Indaptus Therapeutics Inc. (INDP) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade

Dec 24, 2025
pulisher
Dec 24, 2025

Indaptus Therapeutics Inc.: Are They Ready for Takeoff? - StocksToTrade

Dec 24, 2025
pulisher
Dec 24, 2025

Indaptus Therapeutics, Inc.Common Stock (Nasdaq:INDP) Stock Quote - FinancialContent

Dec 24, 2025
pulisher
Dec 24, 2025

Is It Too Late to Buy INDP Stock? - timothysykes.com

Dec 24, 2025
pulisher
Dec 24, 2025

Indaptus Therapeutics (INDP) Stock in Focus on Dec. 24, 2025: $6M Financing, Leadership Reset, and the Dilution Question - ts2.tech

Dec 24, 2025
pulisher
Dec 24, 2025

12 Health Care Stocks Moving In Wednesday's Pre-Market Session - Sahm

Dec 24, 2025
pulisher
Dec 23, 2025

Why Did Indaptus Therapeutics Surge 64% In After-Hours Trading? - Benzinga

Dec 23, 2025
pulisher
Dec 23, 2025

Indaptus Therapeutics, Uipath, Trinity Biotech, Sable Offshore And McDonald's: Why These 5 Stocks Are On Investors' Radars Today - Sahm

Dec 23, 2025
pulisher
Dec 23, 2025

Indaptus Therapeutics : Initial Statement of Beneficial Ownership (Form 3) - marketscreener.com

Dec 23, 2025
pulisher
Dec 23, 2025

Trending Stocks Today | Indaptus Therapeutics Soars 52.9% Post-Market - 富途牛牛

Dec 23, 2025
pulisher
Dec 23, 2025

Indaptus Therapeutics Inc appoints David Lazar as co-chief executive officer - marketscreener.com

Dec 23, 2025
pulisher
Dec 23, 2025

Indaptus Therapeutics Signs Securities Purchase Agreement With David Lazar - TradingView — Track All Markets

Dec 23, 2025
pulisher
Dec 23, 2025

INDP Files 8-K with SEC - Stock Titan

Dec 23, 2025
pulisher
Dec 23, 2025

Indaptus Therapeutics secures new funding and leadership shift - TipRanks

Dec 23, 2025
pulisher
Dec 22, 2025

Indaptus Therapeutics, Inc. announced that it has received $6 million in funding - marketscreener.com

Dec 22, 2025
pulisher
Dec 21, 2025

Indaptus Therapeutics, Inc. announced that it expects to receive $6 million in funding - marketscreener.com

Dec 21, 2025
pulisher
Dec 21, 2025

Can Indaptus Therapeutics Inc. stock hit record highs again2025 Top Gainers & Precise Entry and Exit Recommendations - Улправда

Dec 21, 2025
pulisher
Dec 20, 2025

How buybacks impact Indaptus Therapeutics Inc. stock valueTrade Analysis Summary & AI Forecast for Swing Trade Picks - Улправда

Dec 20, 2025
pulisher
Dec 20, 2025

Breakout Move: Is Indaptus Therapeutics Inc stock attractive for hedge fundsJuly 2025 Patterns & AI Enhanced Market Trend Forecasts - moha.gov.vn

Dec 20, 2025
pulisher
Dec 19, 2025

Will Indaptus Therapeutics Inc. stock outperform value stocksShort Setup & Weekly High Potential Stock Alerts - DonanımHaber

Dec 19, 2025
pulisher
Dec 19, 2025

Is Indaptus Therapeutics Inc. stock a good choice for value investors2025 Valuation Update & Long Hold Capital Preservation Plans - ulpravda.ru

Dec 19, 2025
pulisher
Dec 18, 2025

Published on: 2025-12-19 01:13:33 - moha.gov.vn

Dec 18, 2025
pulisher
Dec 18, 2025

Indaptus Therapeutics Earnings Notes - Trefis

Dec 18, 2025
pulisher
Dec 06, 2025

Indaptus Therapeutics (NASDAQ:INDP) Downgraded by Wall Street Zen to “Sell” - Defense World

Dec 06, 2025
pulisher
Nov 29, 2025

Indaptus Therapeutics (NASDAQ:INDP) Rating Increased to Hold at Wall Street Zen - Defense World

Nov 29, 2025
pulisher
Nov 28, 2025

Pullback Watch: How buybacks impact Indaptus Therapeutics Inc. stock valueMarket Weekly Review & Risk Controlled Stock Pick Alerts - moha.gov.vn

Nov 28, 2025
$106.87
price up icon 0.90%
$34.26
price up icon 1.87%
$118.64
price up icon 10.48%
$99.85
price up icon 1.01%
biotechnology ONC
$337.89
price up icon 5.47%
$175.97
price up icon 3.35%
Capitalizzazione:     |  Volume (24 ore):